Literature DB >> 20586928

Epidemiology and prevention of hepatitis B virus infection in China.

F M Lu1, T Li, S Liu, H Zhuang.   

Abstract

The concept of a hepatitis B vaccine was first introduced into China in 1978. China has been one of the first two developing countries to enact the universal hepatitis B vaccination programme for newborn babies in 1992, and has made tremendous achievements in the control of hepatitis B virus (HBV) infection since then. China now has both low and high endemic regions regarding HBV prevalence co-existing. Although China's drive to stop HBV spread has resulted in changes in HBV epidemic patterns, for the eventual elimination HBV infection in China, it is important to understand the current status of its epidemiology and the aspects of HBV transmission in different regions. More efforts are needed to improve and develop strategies for the control of HBV infection in China, particularly after implementing the policy of universal HBV immunization for all newborns.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20586928     DOI: 10.1111/j.1365-2893.2010.01266.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  34 in total

1.  Psychometrics of chronic liver disease questionnaire in Chinese chronic hepatitis B patients.

Authors:  Kai-Na Zhou; Min Zhang; Qian Wu; Zhen-Hao Ji; Xiao-Mei Zhang; Gui-Hua Zhuang
Journal:  World J Gastroenterol       Date:  2013-06-14       Impact factor: 5.742

2.  Clinicopathological features of hepatitis B virus recurrence after liver transplantation: eleven-year experience.

Authors:  Donghong Zhang; Zuoyi Jiao; Jixiang Han; Hongtai Cao
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

3.  Increased glyceraldehyde-3-phosphate dehydrogenase expression indicates higher survival rates in male patients with hepatitis B virus-accociated hepatocellular carcinoma and cirrhosis.

Authors:  Shuang Liu; Pengfei Zhu; Ling Zhang; Zhuo Li; Quanjun Lv; Sujun Zheng; Yang Wang; Fengmin Lu
Journal:  Exp Ther Med       Date:  2015-02-24       Impact factor: 2.447

4.  Treating chronic hepatitis B virus: Chinese physicians' awareness of the 2010 guidelines.

Authors:  Lai Wei; Ji-Dong Jia; Xin-Hua Weng; Xiao-Guang Dou; Jia-Ji Jiang; Hong Tang; Qin Ning; Qing-Qing Dai; Run-Qin Li; Jie Liu
Journal:  World J Hepatol       Date:  2016-06-28

5.  Dose-response association between hepatitis B surface antigen levels and liver cancer risk in Chinese men and women.

Authors:  Yang Yang; Jing Gao; Hong-Lan Li; Wei Zheng; Gong Yang; Wei Zhang; Xiao Ma; Yu-Ting Tan; Nathaniel Rothman; Yu-Tang Gao; Wong-Ho Chow; Xiao-Ou Shu; Yong-Bing Xiang
Journal:  Int J Cancer       Date:  2016-03-30       Impact factor: 7.396

Review 6.  Point-of-care microfluidic devices for pathogen detection.

Authors:  Behzad Nasseri; Neda Soleimani; Navid Rabiee; Alireza Kalbasi; Mahdi Karimi; Michael R Hamblin
Journal:  Biosens Bioelectron       Date:  2018-05-29       Impact factor: 10.618

Review 7.  Epidemiology of Hepatitis B Virus Infection in China: Current Status and Challenges.

Authors:  Yong-Ping Yan; Hai-Xia Su; Zhao-Hua Ji; Zhong-Jun Shao; Zhong-Shu Pu
Journal:  J Clin Transl Hepatol       Date:  2014-03-15

8.  Prevalence and factors associated with hepatitis B immunization and infection among men who have sex with men in Beijing, China.

Authors:  Chao Wang; YouXin Wang; XiaoJie Huang; Xia Li; Tong Zhang; ManShu Song; LiJuan Wu; Juan Du; XiaoQin Lu; Shuang Shao; FeiFei Zhao; Michele A Ball; Hao Wu; Wei Wang
Journal:  PLoS One       Date:  2012-10-25       Impact factor: 3.240

9.  Evaluation of a programme for prevention of vertical transmission of hepatitis B in a rural block in southern India.

Authors:  Anu Mary Alexander; Jasmin Helen Prasad; Priya Abraham; John Fletcher; Jayaprakash Muliyil; Vinohar Balraj
Journal:  Indian J Med Res       Date:  2013-02       Impact factor: 2.375

Review 10.  HIV and sexually transmissible infections among money boys in China: a data synthesis and meta-analysis.

Authors:  Eric P F Chow; Ka I Iu; Xiaoxing Fu; David P Wilson; Lei Zhang
Journal:  PLoS One       Date:  2012-11-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.